Cargando…

Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study

BACKGROUND: Specific data regarding coronavirus disease 2019 (COVID-19) in patients with neuroendocrine neoplasms (NENs) are lacking. The aim of this study is to describe the characteristics of patients with NENs who tested severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive. MATER...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fazio, Nicola, Gervaso, Lorenzo, Halfdanarson, Thorvardur R., La Salvia, Anna, Hofland, Johannes, Hernando, Jorge, Sonbol, Mohamad B., Garcia-Carbonero, Rocio, Capdevila, Jaume, de Herder, Wouter W., Koumarianou, Anna, Kaltsas, Gregory, Rossi, Maura, Grozinsky-Glasberg, Simona, Oleinikov, Kira, Boselli, Sabrina, Tamayo, Darina, Bagnardi, Vincenzo, Laffi, Alice, Rubino, Manila, Spada, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8241688/ https://www.ncbi.nlm.nih.gov/pubmed/34298375 http://dx.doi.org/10.1016/j.ejca.2021.06.029

Ejemplares similares

Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]
por: Fazio, Nicola, et al.
Publicado: (2022)

Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view
por: Spada, F., et al.
Publicado: (2020)

A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)
por: Laffi, Alice, et al.
Publicado: (2021)

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)
por: Laffi, Alice, et al.
Publicado: (2023)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
por: Spada, Francesca, et al.
Publicado: (2021)

The effect of prophylactic surgery in survival and HRQoL in appendiceal NEN
por: Alexandraki, Krystallenia I., et al.
Publicado: (2020)

The Autophagy Inhibitor Chloroquine, Alone or in Combination with mTOR Inhibitors, Displays Anti-Tumor Effects in In Vitro and In Vivo Lung Carcinoid Models
por: Knigin, Adi, et al.
Publicado: (2021)

Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes
por: Cella, Chiara Alessandra, et al.
Publicado: (2022)

Calcitonin Non-Secreting Mixed Medullary-Papillary Thyroid Carcinoma: Report of a Rare Entity and Therapeutic Implications
por: Oleinikov, Kira, et al.
Publicado: (2021)

Prognostic Factors in Advanced Adrenocortical Carcinoma: Summary of a National Referral Center’s 20 years of Experience
por: Arnon, Johnathan, et al.
Publicado: (2022)

Dosimetry after peptide receptor radionuclide therapy: impact of reduced number of post-treatment studies on absorbed dose calculation and on patient management
por: Chicheportiche, Alexandre, et al.
Publicado: (2020)

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy
por: Twito, Orit, et al.
Publicado: (2023)

Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
por: Fazio, Nicola, et al.
Publicado: (2021)

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
por: Hofland, Johannes, et al.
Publicado: (2020)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

Can a penalized-likelihood estimation algorithm be used to reduce the injected dose or the acquisition time in (68)Ga-DOTATATE PET/CT studies?
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

Peptide Receptor Radionuclide Therapy for the Treatment of Pancreatic Neuroendocrine Tumors: Recent Insights
por: Starr, Jason S, et al.
Publicado: (2020)

Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
por: Uri, Inbal, et al.
Publicado: (2018)

Biomarker evaluation in radically resectable locally advanced gastric cancer treated with neoadjuvant chemotherapy: an evidence reappraisal
por: Gervaso, Lorenzo, et al.
Publicado: (2021)

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
por: Fazio, Nicola, et al.
Publicado: (2022)

Simple model for estimation of absorbed dose by organs and tumors after PRRT from a single SPECT/CT study
por: Chicheportiche, Alexandre, et al.
Publicado: (2021)

Non-functioning pancreatic neuroendocrine tumors: Surgery or observation?
por: Bar-Moshe, Yehonatan, et al.
Publicado: (2017)

Survival and Incidence Patterns of Pancreatic Neuroendocrine Tumors Over the Last 2 Decades: A SEER Database Analysis
por: Sonbol, Mohamad Bassam, et al.
Publicado: (2022)

Mayo Clinic Cancer Center Experience of Metastatic Extramammary Paget Disease 1998-2012
por: Padrnos, Leslie, et al.
Publicado: (2016)

Pancreatic neuroendocrine tumors with transformation to insulinoma: an unusual presentation of a rare disease
por: Nahmias, Avital, et al.
Publicado: (2015)

Advances in systemic therapy for advanced pancreatobiliary malignancies
por: Halfdanarson, Thorvardur R, et al.
Publicado: (2013)

Primary neuroendocrine carcinoma of the brain
por: Reed, Clay T, et al.
Publicado: (2019)

Current best practice in the management of neuroendocrine tumors
por: Tsoli, Marina, et al.
Publicado: (2018)

Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)
por: Hofland, Johannes, et al.
Publicado: (2021)

Vandetanib induces a marked anti-tumor effect and amelioration of ectopic Cushing’s syndrome in a medullary thyroid carcinoma patient
por: Bseiso, Hashem, et al.
Publicado: (2016)

Development of a quality of life questionnaire for patients with pancreatic neuroendocrine tumours (the PANNET module)
por: Ramage, John K., et al.
Publicado: (2022)

Pathogenesis and Clinical Management of Mesenteric Fibrosis in Small Intestinal Neuroendocine Neoplasms: A Systematic Review
por: Koumarianou, Anna, et al.
Publicado: (2020)

Metachronous Testicular Metastases from Merkel Cell Carcinoma (MCC): A Case Report and Literature Review
por: Laffi, Alice, et al.
Publicado: (2022)

Pilot Study Characterizing the Hematology-Oncology Fellow Job Search Process: Tools Used and Identification of Potential New Resources
por: Marshall, Ariela L., et al.
Publicado: (2021)

The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review
por: Zagami, Paola, et al.
Publicado: (2020)

Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
por: Saberzadeh-Ardestani, Bahar, et al.
Publicado: (2023)

Practical recommendations for the management of patients with gastroenteropancreatic and thoracic (carcinoid) neuroendocrine neoplasms in the COVID-19 era
por: Rodriguez-Freixinos, Víctor, et al.
Publicado: (2021)

Combination Systemic Therapies in Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): A Comprehensive Review of Clinical Trials and Prospective Studies
por: Diamantopoulos, Leonidas N., et al.
Publicado: (2023)

Targeted Alpha-Particle Therapy: A Review of Current Trials
por: Jang, Albert, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_glo7qsv9fh6bmnv1i96aiodehu